aetherAI (7803) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 雲象科技-創

aetherAI (7803) reported revenue of NT$5.8 million for Oct 2026, -88.1% year on year and -34.6% from the previous month. Revenue for Jan–Oct 2026 was NT$55 million (-70.7% year on year).

In Oct 2026, it ranked No. 137 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$1.1 million24/10Nov 2024 NT$1.9 millionDec 2024 NT$48.2 millionJan 2025 NT$243,000Feb 2025 NT$215,00025/02Mar 2025 NT$11.1 millionApr 2025 NT$15.4 millionMay 2025 NT$1.1 millionJun 2025 NT$21.1 million25/06Jul 2025 NT$2.3 millionAug 2025 NT$63.9 millionSep 2025 NT$24.1 millionOct 2025 NT$48.2 million25/10Nov 2025 NT$884,000Dec 2025 NT$5.2 millionJan 2026 NT$1.6 millionFeb 2026 NT$731,00026/02Mar 2026 NT$8.5 millionApr 2026 NT$1.4 millionMay 2026 NT$16.6 millionJun 2026 NT$3.2 million26/06Jul 2026 NT$1.4 millionAug 2026 NT$7 millionSep 2026 NT$8.8 millionOct 2026 NT$5.8 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$5.8 million-88.1%-34.6%
Sep 2026NT$8.8 million-63.6%+24.9%
Aug 2026NT$7 million-89.0%+418.2%
Jul 2026NT$1.4 million-40.0%-57.3%
Jun 2026NT$3.2 million-84.9%-80.8%
May 2026NT$16.6 million+1,440.6%+1,048.5%
Apr 2026NT$1.4 million-90.6%-82.9%
Mar 2026NT$8.5 million-24.2%+1,056.5%
Feb 2026NT$731,000+240.0%-54.7%
Jan 2026NT$1.6 million+564.6%-69.2%
Dec 2025NT$5.2 million-89.1%+493.7%
Nov 2025NT$884,000-53.7%-98.2%
Oct 2025NT$48.2 million+4,185.0%+99.8%
Sep 2025NT$24.1 million+3,558.3%-62.2%
Aug 2025NT$63.9 million+1,328.1%+2,720.2%
Jul 2025NT$2.3 million+79.8%-89.3%
Jun 2025NT$21.1 million+1,535.0%+1,856.5%
May 2025NT$1.1 million-28.7%-93.0%
Apr 2025NT$15.4 million+32.6%+38.1%
Mar 2025NT$11.1 million-19.7%+5,084.2%
Feb 2025NT$215,000-97.0%-11.5%
Jan 2025NT$243,000-96.9%-99.5%
Dec 2024NT$48.2 million+1,346.4%+2,423.2%
Nov 2024NT$1.9 million-91.4%+69.6%
Oct 2024NT$1.1 million—+70.6%

Jan–Oct 2026 cumulative: NT$55 million (-70.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: aetherAI vs PEC / aetherAI vs Lotus Pharm / aetherAI vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

Company remark (original Chinese)

去年同期有專案驗收完成,故認列收入。

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16